MedTrace Logo

Validation of Salivary Proteomic Biomarkers for Early Detection of Oral Cancer in Egyptian Population

NCT06471270 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-06-24

No results posted yet for this study

Summary

The present investigation was conducted on 100 individuals allocated into four groups; 25 healthy controls, 25 patients having OPMDs with dysplasia; 25 patients having OPMDs without dysplasia, and 25 oral cancer patients. Demographic data including data related to different risk factors, modified gingival index, oral hygiene level, in addition to salivary levels of IL-6, IL-8 and sCD44 were assessed.

Conditions

  • Oral Cancer

Interventions

DIAGNOSTIC_TEST

histologic evaluation

histologic evaluation

DIAGNOSTIC_TEST

biochemical analysis

IL-6, IL-8 and sCD44

DIAGNOSTIC_TEST

clinical examination

clinical examination

Sponsors & Collaborators

  • British University In Egypt

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-15
Primary Completion
2024-03-01
Completion
2024-03-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06471270 on ClinicalTrials.gov